Lombard Odier Asset Management (USA) Corp - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 98 filers reported holding REPROS THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (USA) Corp ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2014$7,785,000
-26.9%
450,000
-25.0%
0.41%
-0.5%
Q1 2014$10,644,000
-3.1%
600,0000.0%0.41%
-12.3%
Q4 2013$10,980,000
+17.1%
600,000
+71.4%
0.47%0.0%
Q3 2013$9,380,000
-10.0%
350,000
-38.1%
0.47%
-19.4%
Q2 2013$10,424,000565,0000.58%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Allegis Investment Advisors, LLC 342,709$569,0000.29%
GENERAL AMERICAN INVESTORS CO INC 396,123$638,0000.07%
Alambic Investment Management, L.P. 69,191$111,0000.03%
Acrospire Investment Management LLC 15,119$24,0000.02%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 98,486$158,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,030$507,0000.01%
SIMPLEX TRADING, LLC 86,054$138,0000.01%
A.R.T. Advisors, LLC 34,315$55,0000.00%
Mariner Wealth Advisors-Cincinnati, LLC 11,000$18,0000.00%
Renaissance Technologies 561,713$904,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders